Daiichi Sankyo SWOT Analysis, Competitors & USP
SWOT analysis of Daiichi Sankyo analyses the brand by its strengths, weaknesses, opportunities & threats. In Daiichi Sankyo SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.
SWOT Analysis is a proven management framework which enables a brand like Daiichi Sankyo to benchmark its business & performance as compared to the competitors. Daiichi Sankyo is one of the leading brands in the pharma and healthcare sector.
The table below lists the Daiichi Sankyo SWOT (Strengths, Weaknesses, Opportunities, Threats), top Daiichi Sankyo competitors and includes its target market, segmentation, positioning & Unique Selling Proposition (USP).
In this article:
| Daiichi Sankyo Brand Analysis | |
|---|---|
| Parent Company |
Daiichi Sankyo |
| Category |
Pharmaceutical |
| Sector | |
| Tagline/ Slogan |
Passion for innovation, Compassion for patients |
| USP |
It is one of the largest pharmaceutical company in Japan |
| Daiichi Sankyo STP | |
| Segment |
Oncology & Cardiovascular diseases |
| Target Group |
Healthcare professionals offereing treatments to patients suffering from cancer or cardiovascular disease |
| Positioning |
They are global pharma innovator who aim to provide pharmaceuticals in shortest possible time |
| SWOT Analysis of Daiichi Sankyo | |
| Daiichi Sankyo Strengths |
Below are the Strengths in the SWOT Analysis of Daiichi Sankyo: 1. Has a strong workforce of over 30,000 employees 2. Leading producer of Benicar which is angiotensin II receptor antagonist 3. It is one of the largest pharmaceutical company in Japan 4. Strong presence in US, Europe, India, China, Brazil, Thailand and some others |
| Daiichi Sankyo Weaknesses |
Here are the weaknesses in the Daiichi Sankyo SWOT Analysis: 1. Despite being a strong brand, had a limited market share due to international competitors 2. Operates in limited segments such as Oncology & Cardiovascular segment |
| Daiichi Sankyo Opportunities |
Following are the Opportunities in Daiichi Sankyo SWOT Analysis: 1. Increasing world population and more awareness about health 2. More people suffering from chronic diseases such as cancer, cardiovascular diseases 3. Increasing awareness of healthcare solutions |
| Daiichi Sankyo Threats |
The threats in the SWOT Analysis of Daiichi Sankyo are as mentioned: 1. Natural disasters in Japan 2. increasing stringency in drug development guidelines 3. Global economic slowdown |
| Daiichi Sankyo Competition | |
| Daiichi Sankyo Competitors |
Below are the top 4 competitors of Daiichi Sankyo: 1. Takeda Pharmaceuticals 3. Astellas pharmaceuticals 4. AstraZeneca |
This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.
Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to Daiichi Sankyo. This section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2500 brands from over 20 industry sectors.
Continue Reading:
The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute
